This, coupled with results showing that administration of an ACE2 inhibitor improved the pathology of inflammatory bowel disease [12], suggests that inhibition of ACE2 may be beneficial in inflammatory diseases such as arthritis. This evidence concerns the gene ACE2 and arthritic joint disease.